Caesarea Labs develops electronic design automation software for post-silicon validation, the stage of chip development in which physical silicon is tested rather than simulated. Its platform addresses circuit edit, the workflow that specifies the physical modifications a focused ion beam operator makes to debug or prototype a chip. The software converts a design engineer's solution hypothesis and chip layout into a layout-level edit design that a lab can review and accept, replacing a manual exchange that the company says can stretch from weeks to months.
The platform is offered to the organizations that run circuit edit: semiconductor manufacturers with internal post-silicon validation labs, independent labs that sell circuit edit as a service, academic and research institutions with circuit-edit-capable tools, and foundries that also perform automated mask repair. Caesarea Labs keeps full-chip layout data inside the customer's infrastructure and exports only the redacted subset a specific edit requires, a design the company presents as limiting the exposure of chip intellectual property.
Quick Facts
When was Caesarea Labs' last funding round?
Caesarea Labs' most recent funding round was for $20k (USD) in September 2024.
How much disclosed funding has Caesarea Labs raised?
As of Sep 9, 2024, Caesarea Labs has disclosed funding of $20k (USD).